Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

King Faisal Specialist Hospital & Research Center6 enrolled

Overview

Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX

It's a study of adjuvant colon carcinoma using ELOXatin/5-FU based chemotherapeutic regimen called ACCELOX as a definitive curative therapy.

Study Type

OBSERVATIONAL

Enrollment

Registry

Sex: ALLMin age: 14 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with Adjuvant Colon Cancer Exclusion Criteria: * Patients with diagnosis other than Colon Cancer.

Kfsh & Rc

Riyadh, Saudi Arabia

OS, PFS, DFS

Time frame: For the duration of the experiment

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.